MALAT1 and thyroid cancer: Specifically, this study revealed that, in thyroid cancer, MALAT-1 and insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2), a member of RNA binding proteins, were expressed while mir-204 was expressed poorly.